Kala Pharmaceuticals, Inc. (KALA) financial statements (2022 and earlier)

Company profile

Business Address 1167 MASSACHUSETTS AVENUE
ARLINGTON, MA 02476
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments92,136153,54085,449170,898114,565
Cash and cash equivalents92,13677,26485,449170,898114,565
Short-term investments 76,276   
Restricted cash and investments2,042    
Receivables17,4559,85413,098  
Inventory, net of allowances, customer advances and progress billings8,6395,2294,6484,095 
Inventory8,6395,2294,6484,095 
Prepaid expense3,1832,1501,590532452
Other current assets   477196
Other undisclosed current assets9116066991,026 
Total current assets:124,366171,379105,484177,028115,213
Noncurrent Assets
Inventory, Noncurrent9,5786,2193,778  
Operating lease, right-of-use asset1,29927,85329,781
Property, plant and equipment2,7223,1662,6982,166786
Restricted cash and investments70012,49212,58212,206134
Other undisclosed noncurrent assets762497 29,566 
Total noncurrent assets:15,06150,22748,83943,938920
TOTAL ASSETS:139,427221,606154,323220,966116,133
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities25,88520,69523,44716,5477,791
Accounts payable4,8991,7242,5185,4461,202
Accrued liabilities20,98618,97120,92911,1016,589
Debt  1,327 6,667
Business combination, contingent consideration, liability3,817    
Other undisclosed current liabilities7,7201,530 463 
Total current liabilities:37,42222,22524,77417,01014,458
Noncurrent Liabilities
Long-term debt and lease obligation79,47799,38699,85798,97811,987
Long-term debt, excluding current maturities78,92972,24371,18470,22611,987
Finance lease, liability54827,14328,673
Capital lease obligations28,752 
Liabilities, other than long-term debt4,841   9
Other liabilities    9
Business combination, contingent consideration, liability4,841    
Other undisclosed noncurrent liabilities883    
Total noncurrent liabilities:85,20199,38699,85798,97811,996
Total liabilities:122,623121,611124,631115,98826,454
Stockholders' equity
Stockholders' equity attributable to parent16,80499,99529,692104,97889,679
Common stock6659363425
Additional paid in capital559,126499,715325,112306,053224,025
Accumulated other comprehensive income 4   
Accumulated deficit(542,388)(399,783)(295,456)(201,109)(134,371)
Total stockholders' equity:16,80499,99529,692104,97889,679
TOTAL LIABILITIES AND EQUITY:139,427221,606154,323220,966116,133

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues11,2406,3626,074  
Gross profit:11,2406,3626,074  
Operating expenses(141,485)(102,593)(94,298)(64,721)(39,875)
Operating loss:(130,245)(96,231)(88,224)(64,721)(39,875)
Nonoperating income
(Investment Income, Nonoperating)
1044932,3571,687527
Interest and debt expense(13,775)(8,589)(8,480)(3,704)(1,019)
Loss before gain (loss) on sale of properties:(143,916)(104,327)(94,347)(66,738)(40,367)
Other undisclosed net income (loss)1,311   (1,844)
Net loss available to common stockholders, diluted:(142,605)(104,327)(94,347)(66,738)(42,211)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(142,605)(104,327)(94,347)(66,738)(42,211)
Other comprehensive income (loss)(4)4   
Comprehensive loss, net of tax, attributable to parent:(142,609)(104,323)(94,347)(66,738)(42,211)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: